Tevogen Bio Holdings Inc (TVGN) Stock Observes -11.95% 200-Day Moving Average

The stock of Tevogen Bio Holdings Inc (TVGN) has seen a 4.83% increase in the past week, with a -19.18% drop in the past month, and a 247.26% flourish in the past quarter. The volatility ratio for the week is 12.28%, and the volatility levels for the past 30 days are at 11.96% for TVGN. The simple moving average for the past 20 days is 2.51% for TVGN’s stock, with a -11.95% simple moving average for the past 200 days.

Is It Worth Investing in Tevogen Bio Holdings Inc (NASDAQ: TVGN) Right Now?

The 36-month beta value for TVGN is also noteworthy at -1.22. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

The public float for TVGN is 24.92M, and at present, short sellers hold a 4.72% of that float. The average trading volume of TVGN on December 31, 2024 was 16.87M shares.

TVGN) stock’s latest price update

The stock price of Tevogen Bio Holdings Inc (NASDAQ: TVGN) has jumped by 0.84 compared to previous close of 1.05. Despite this, the company has seen a gain of 4.83% in its stock price over the last five trading days. globenewswire.com reported 2024-12-26 that WARREN, N.J., Dec. 26, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), will host panel discussions at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California.

TVGN Trading at -28.50% from the 50-Day Moving Average

After a stumble in the market that brought TVGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.98% of loss for the given period.

Volatility was left at 11.96%, however, over the last 30 days, the volatility rate increased by 12.28%, as shares sank -12.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -40.10% lower at present.

During the last 5 trading sessions, TVGN rose by +2.01%, which changed the moving average for the period of 200-days by -83.30% in comparison to the 20-day moving average, which settled at $1.0314. In addition, Tevogen Bio Holdings Inc saw -90.49% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at TVGN starting from Flomenberg Neal, who sale 1,078,600 shares at the price of $1.62 back on Oct 17 ’24. After this action, Flomenberg Neal now owns 4,254,302 shares of Tevogen Bio Holdings Inc, valued at $1,747,332 using the latest closing price.

Desai Kirti, the Chief Financial Officer of Tevogen Bio Holdings Inc, purchase 3,000 shares at $0.82 during a trade that took place back on Jun 12 ’24, which means that Desai Kirti is holding 9,699,186 shares at $2,460 based on the most recent closing price.

Stock Fundamentals for TVGN

The total capital return value is set at 7.32. Equity return is now at value -124.74, with -14.86 for asset returns.

Based on Tevogen Bio Holdings Inc (TVGN), the company’s capital structure generated -0.76 points at debt to capital in total, while cash flow to debt ratio is standing at -3.62. The debt to equity ratio resting at -0.43. The interest coverage ratio of the stock is -105.71.

Currently, EBITDA for the company is 0.19 million with net debt to EBITDA at -0.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.34.

Conclusion

In summary, Tevogen Bio Holdings Inc (TVGN) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts